OpenURL Connection Search

Select item for more details and to access through your institution.

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.
Published in:
Neurological Sciences, 2004, v. 25, n. 5, p. 301, doi. 10.1007/s10072-004-0358-5
By:
- Zetterberg, H.;
- Blennow, K.
Publication type:
Article
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Published in:
Neurological Sciences, 2002, v. 23, p. S96, doi. 10.1007/s100720200086
By:
- Parnetti, L.;
- Amici, S.;
- Lanari, A.;
- Romani, C.;
- Antognelli, C.;
- Andreasen, N.;
- Minthon, L.;
- Davidsson, P.;
- Pottel, H.;
- Blennow, K.;
- Gallai, V.
Publication type:
Article
Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.
Published in:
2011
By:
- Chalbot S;
- Zetterberg H;
- Blennow K;
- Fladby T;
- Andreasen N;
- Grundke-Iqbal I;
- Iqbal K;
- Chalbot, Sonia;
- Zetterberg, Henrik;
- Blennow, Kaj;
- Fladby, Tormod;
- Andreasen, Niels;
- Grundke-Iqbal, Inge;
- Iqbal, Khalid
Publication type:
journal article
Genetic association of sequence variants near AGER/NOTCH4 and dementia.
Published in:
2011
By:
- Bennet AM;
- Reynolds CA;
- Eriksson UK;
- Hong MG;
- Blennow K;
- Gatz M;
- Alexeyenko A;
- Pedersen NL;
- Prince JA;
- Bennet, Anna M;
- Reynolds, Chandra A;
- Eriksson, Ulrika K;
- Hong, Mun-Gwan;
- Blennow, Kaj;
- Gatz, Margaret;
- Alexeyenko, Andrey;
- Pedersen, Nancy L;
- Prince, Jonathan A
Publication type:
journal article
Cerebrospinal fluid biomarkers for Alzheimer's disease: diagnostic performance in a homogeneous mono-center population.
Published in:
2011
By:
- Johansson P;
- Mattsson N;
- Hansson O;
- Wallin A;
- Johansson JO;
- Andreasson U;
- Zetterberg H;
- Blennow K;
- Svensson J
Publication type:
Journal Article
Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.
Published in:
2011
By:
- Rolstad S;
- Berg AI;
- Bjerke M;
- Blennow K;
- Johansson B;
- Zetterberg H;
- Wallin A;
- Rolstad, Sindre;
- Berg, Anne Ingeborg;
- Bjerke, Maria;
- Blennow, Kaj;
- Johansson, Boo;
- Zetterberg, Henrik;
- Wallin, Anders
Publication type:
journal article
Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
Published in:
2011
By:
- Sagare AP;
- Deane R;
- Zetterberg H;
- Wallin A;
- Blennow K;
- Zlokovic BV;
- Sagare, Abhay P;
- Deane, Rashid;
- Zetterberg, Henrik;
- Wallin, Anders;
- Blennow, Kaj;
- Zlokovic, Berislav V
Publication type:
journal article
Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF amyloid-β42, and dementia.
Published in:
2010
By:
- Bennet AM;
- Reynolds CA;
- Gatz M;
- Blennow K;
- Pedersen NL;
- Prince JA;
- Bennet, Anna M;
- Reynolds, Chandra A;
- Gatz, Margaret;
- Blennow, Kaj;
- Pedersen, Nancy L;
- Prince, Jonathan A
Publication type:
journal article
Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.
Published in:
2010
By:
- Hertze J;
- Minthon L;
- Zetterberg H;
- Vanmechelen E;
- Blennow K;
- Hansson O;
- Hertze, Joakim;
- Minthon, Lennart;
- Zetterberg, Henrik;
- Vanmechelen, Eugeen;
- Blennow, Kaj;
- Hansson, Oskar
Publication type:
journal article
Acute effect on the A[beta] isoform pattern in CSF in response to [gamma]-secretase modulator and inhibitor treatment in dogs.
Published in:
2010
By:
- Portelius E;
- Van Broeck B;
- Andreasson U;
- Gustavsson MK;
- Mercken M;
- Zetterberg H;
- Borghys H;
- Blennow K
Publication type:
Journal Article
Cystatin C Levels are Positively Correlated with both Abeta42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls.
Published in:
2010
By:
- Sundelöf J;
- Sundström J;
- Hansson O;
- Eriksdotter-Jönhagen M;
- Giedraitis V;
- Larsson A;
- Degerman-Gunnarsson M;
- Ingelsson M;
- Minthon L;
- Blennow K;
- Kilander L;
- Basun H;
- Lannfelt L
Publication type:
Journal Article
Reduced Levels of Amyloid-beta-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients.
Published in:
2009
By:
- Hansson SF;
- Andréasson U;
- Wall M;
- Skoog I;
- Andreasen N;
- Wallin A;
- Zetterberg H;
- Blennow K
Publication type:
Journal Article
Normal levels of clusterin in cerebrospinal fluid in Alzheimer's disease, and no change after acute ischemic stroke.
Published in:
2001
By:
- Lidström, A-M.;
- Hesse, C.;
- Rosengren, L.;
- Fredman, P.;
- Davidsson, P.;
- Blennow, K.
Publication type:
journal article
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Published in:
European Journal of Neurology, 2017, v. 24, n. 5, p. 703, doi. 10.1111/ene.13274
By:
- Håkansson, I.;
- Tisell, A.;
- Cassel, P.;
- Blennow, K.;
- Zetterberg, H.;
- Lundberg, P.;
- Dahle, C.;
- Vrethem, M.;
- Ernerudh, J.
Publication type:
Article
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Published in:
European Journal of Neurology, 2017, v. 24, n. 1, p. 112, doi. 10.1111/ene.13162
By:
- Mellergård, J.;
- Tisell, A.;
- Blystad, I.;
- Grönqvist, A.;
- Blennow, K.;
- Olsson, B.;
- Dahle, C.;
- Vrethem, M.;
- Lundberg, P.;
- Ernerudh, J.
Publication type:
Article
Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Published in:
European Journal of Neurology, 2016, v. 23, n. 4, p. 796, doi. 10.1111/ene.12942
By:
- Constantinescu, R.;
- Krýsl, D.;
- Bergquist, F.;
- Andrén, K.;
- Malmeström, C.;
- Asztély, F.;
- Axelsson, M.;
- Menachem, E. B.;
- Blennow, K.;
- Rosengren, L.;
- Zetterberg, H.
Publication type:
Article
Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
Published in:
European Journal of Neurology, 2014, v. 21, n. 3, p. 486, doi. 10.1111/ene.12336
By:
- Shahim, P.;
- Rejdak, R.;
- Ksiazek, P.;
- Blennow, K.;
- Zetterberg, H.;
- Mattsson, N.;
- Rejdak, K.
Publication type:
Article
Cerebrospinal fluid biomarkers of white matter lesions – cross-sectional results from the LADIS study.
Published in:
European Journal of Neurology, 2010, v. 17, n. 3, p. 377, doi. 10.1111/j.1468-1331.2009.02808.x
By:
- Jonsson, M.;
- Zetterberg, H.;
- van Straaten, E.;
- Lind, K.;
- Syversen, S.;
- Edman, Å.;
- Blennow, K.;
- Rosengren, L.;
- Pantoni, L.;
- Inzitari, D.;
- Wallin, A.
Publication type:
Article
Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1.
Published in:
European Journal of Neurology, 2008, v. 15, n. 9, p. 947, doi. 10.1111/j.1468-1331.2008.02217.x
By:
- Winblad, S.;
- Månsson, J. E.;
- Blennow, K.;
- Jensen, C.;
- Samuelsson, L.;
- Lindberg, C.
Publication type:
Article
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.
Published in:
European Journal of Neurology, 2007, v. 14, n. 12, p. 1329, doi. 10.1111/j.1468-1331.2007.01972.x
By:
- Zetterberg, H.;
- Jacobsson, J.;
- Rosengren, L.;
- Blennow, K.;
- Andersen, P. M.
Publication type:
Article
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus.
Published in:
European Journal of Neurology, 2007, v. 14, n. 3, p. 248, doi. 10.1111/j.1468-1331.2006.01553.x
By:
- Tullberg, M.;
- Blennow, K.;
- Månsson, J.-E.;
- Fredman, P.;
- Tisell, M.;
- Wikkelsö, C.
Publication type:
Article
Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus.
Published in:
European Journal of Neurology, 2004, v. 11, n. 1, p. 17, doi. 10.1046/j.1351-5101.2003.00698.x
By:
- Tisell, M.;
- Tullberg, M.;
- Månsson, J.-E.;
- Fredman, P.;
- Blennow, K.;
- Wikkelsø, C.
Publication type:
Article
Focused Workshops.
Published in:
2000
By:
- Ekman, R.;
- Davidson, P.;
- Blennow, K.;
- Rajda, C.;
- Haghighi, S.;
- Rosengren, L.;
- Anderson, O.;
- Bergquist, J.;
- Vécsei, L.;
- Seres, E.;
- Opara, J.;
- Rossi, B.;
- Caboncini, M.C.;
- Bongioanni, P.;
- Gazzarri, G.;
- Zannoni, G.;
- Bonfiglio, L.;
- Stampacchia, G.
Publication type:
Abstract
Medial Temporal Lobe Atrophy Increases the Specificity of Cerebrospinal Fluid Biomarkers in Alzheimer Disease with Minor Cerebrovascular Changes.
Published in:
Acta Radiologica, 2009, v. 50, n. 6, p. 674, doi. 10.1080/02841850902912028
By:
- Y. Zhang;
- Londos, E.;
- Minthon, L.;
- Wattmo, C.;
- Blennow, K.;
- Liu, H. J.;
- Bronge, L.;
- Aspelin, P.;
- Wahlund, L. -O.
Publication type:
Article
Cerebrospinal fluid GAP-43 in early multiple sclerosis.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 3, p. 1, doi. 10.1177/2055217318792931
By:
- Rot, U.;
- Sandelius, Å.;
- Emeršič, A.;
- Zetterberg, H.;
- Blennow, K.
Publication type:
Article
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.
Published in:
Molecular Psychiatry, 2014, v. 19, n. 2, p. 148, doi. 10.1038/mp.2013.18
By:
- Andreasson, U;
- Lautner, R;
- Schott, J M;
- Mattsson, N;
- Hansson, O;
- Herukka, S-K;
- Helisalmi, S;
- Ewers, M;
- Hampel, H;
- Wallin, A;
- Minthon, L;
- Hardy, J;
- Blennow, K;
- Zetterberg, H
Publication type:
Article
Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.
Published in:
Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00455-y
By:
- Jeppsson, A.;
- Sandelius, Å.;
- Zettergren, A.;
- Kern, S.;
- Skoog, I.;
- Blennow, K.;
- Zetterberg, H.;
- Wikkelsø, C.;
- Hellström, P.;
- Tullberg, M.
Publication type:
Article
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.
Published in:
Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00585-7
By:
- Minta, K.;
- Brinkmalm, G.;
- Janelidze, S.;
- Sjödin, S.;
- Portelius, E.;
- Stomrud, E.;
- Zetterberg, H.;
- Blennow, K.;
- Hansson, O.;
- Andreasson, U.
Publication type:
Article
CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
Published in:
Alzheimer's Research & Therapy, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13195-019-0534-8
By:
- Miners, J. S.;
- Kehoe, P. G.;
- Love, S.;
- Zetterberg, H.;
- Blennow, K.
Publication type:
Article
Use of CSF biomarkers in Alzheimer’s disease clinical trials.
Published in:
Journal of Nutrition, Health & Aging, 2009, v. 13, n. 4, p. 358, doi. 10.1007/s12603-009-0043-8
By:
- BLENNOW, K.;
- ZETTERBERG, H.
Publication type:
Article
Evolution of Abeta42 and Abeta40 Levels and Abeta42/Abeta40 Ratio in Plasma during Progression of Alzheimer's Disease: A Multicenter Assessment.
Published in:
2009
By:
- Blennow K;
- De Meyer G;
- Hansson O;
- Minthon L;
- Wallin A;
- Zetterberg H;
- Lewczuk P;
- Vanderstichele H;
- Vanmechelen E;
- Kornhuber J;
- Wiltfang J
Publication type:
Journal Article
Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment.
Published in:
Journal of Nutrition, Health & Aging, 2009, v. 13, n. 3, p. 205, doi. 10.1007/s12603-009-0059-0
By:
- BLENNOW, K.;
- DE MEYER, G.;
- HANSSON, O.;
- MINTHON, L.;
- WALLIN, A.;
- ZETTERBERG, H.;
- LEWCZUK, P.;
- VANDERSTICHELE, H.;
- VANMECHELEN, E.;
- KORNHUBER, J.;
- WILTFANG, J.
Publication type:
Article
Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease.
Published in:
Annals of the New York Academy of Sciences, 2007, v. 1097, p. 114, doi. 10.1196/annals.1379.012
By:
- De LEON, M. J.;
- MOSCONI, L.;
- BLENNOW, K.;
- DeSANTI, S.;
- ZINKOWSKI, R.;
- MEHTA, P. D.;
- PRATICO, D.;
- TSUI, W.;
- LOUIS, L. A. SAINT;
- SOBANSKA, L.;
- BRYS, M.;
- LI, Y.;
- RICH, K.;
- RINNE, J.;
- RUSINEK, H.
Publication type:
Article
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
Published in:
Journal of Neuroscience Research, 2003, v. 72, n. 4, p. 520, doi. 10.1002/jnr.10599
By:
- J. Sáez-Valero;
- L.R. Fodero;
- M. Sjögren;
- N. Andreasen;
- S. Amici;
- V. Gallai;
- H. Vanderstichele;
- E. Vanmechelen;
- L. Parnetti;
- K. Blennow;
- D. H. Small
Publication type:
Article
Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides.
Published in:
Neurodegenerative Diseases, 2008, v. 5, n. 5, p. 268, doi. 10.1159/000119457
By:
- Höglund, K.;
- Hansson, O.;
- Buchhave, P.;
- Zetterberg, H.;
- Lewczuk, P.;
- Londos, E.;
- Blennow, K.;
- Minthon, L.;
- Wiltfang, J.
Publication type:
Article
Mid-life adiposity factors relate to blood-brain barrier integrity in late life.
Published in:
2007
By:
- Gustafson DR;
- Karlsson C;
- Skoog I;
- Rosengren L;
- Lissner L;
- Blennow K
Publication type:
Journal Article
Mid-life adiposity factors relate to blood–brain barrier integrity in late life.
Published in:
Journal of Internal Medicine, 2007, v. 262, n. 6, p. 643, doi. 10.1111/j.1365-2796.2007.01869.x
By:
- Gustafson, D. R.;
- Karlsson, C.;
- Skoog, I.;
- Rosengren, L.;
- Lissner, L.;
- Blennow, K.
Publication type:
Article
Mild cognitive impairment -- beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
Published in:
2004
By:
- Winblad B;
- Palmer K;
- Kivipelto M;
- Jelic V;
- Fratiglioni L;
- Wahlund L;
- Nordberg A;
- Bäckman L;
- Albert M;
- Almkvist O;
- Arai H;
- Basun H;
- Blennow K;
- de Leon M;
- DeCarli C;
- Erkinjuntti T;
- Giacobini E;
- Graff C;
- Hardy J;
- Jack C
Publication type:
Journal Article
CSF biomarkers for mild cognitive impairment.
Published in:
Journal of Internal Medicine, 2004, v. 256, n. 3, p. 224, doi. 10.1111/j.1365-2796.2004.01368.x
By:
- Blennow, K.
Publication type:
Article
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
Published in:
Journal of Internal Medicine, 2004, v. 256, n. 3, p. 240, doi. 10.1111/j.1365-2796.2004.01380.x
By:
- Winblad, B.;
- Palmer, K.;
- Kivipelto, M.;
- Jelic, V.;
- Fratiglioni, L.;
- Wahlund, L.-O.;
- Nordberg, A.;
- Backman, L.;
- Albert, M.;
- Almkvist, O.;
- Arai, H.;
- Basun, H.;
- Blennow, K.;
- De Leon, M.;
- Decarli, C.;
- Erkinjuntti, T.;
- Giacobini, E.;
- Graff, C.;
- Hardy, J.;
- Jack, C.
Publication type:
Article
Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer's Disease.
Published in:
Dementia & Geriatric Cognitive Disorders, 2012, v. 33, n. 2/3, p. 174, doi. 10.1159/000338181
By:
- Pernber, Z.;
- Blennow, K.;
- Bogdanovic, N.;
- Månsson, J.-E.;
- Blomqvist, M.
Publication type:
Article
Progression from Mild to Pronounced MCI Is Not Associated with Cerebrospinal Fluid Biomarker Deviations.
Published in:
Dementia & Geriatric Cognitive Disorders, 2011, v. 32, n. 3, p. 193, doi. 10.1159/000333034
By:
- Wallin, A.;
- Göthlin, M.;
- Gustavsson, M.;
- Zetterberg, H.;
- Eckerström, C.;
- Blennow, K.;
- Edman, Å.;
- Lind, K.;
- Nordlund, A.;
- Rolstad, S.
Publication type:
Article
Combination of Hippocampal Volume and Cerebrospinal Fluid Biomarkers Improves Predictive Value in Mild Cognitive Impairment.
Published in:
Dementia & Geriatric Cognitive Disorders, 2010, v. 29, n. 4, p. 294, doi. 10.1159/000289814
By:
- Eckerström, C.;
- Andreasson, U.;
- Olsson, E.;
- Rolstad, S.;
- Blennow, K.;
- Zetterberg, H.;
- Malmgren, H.;
- Edman, Å.;
- Wallin, A.
Publication type:
Article
Pittsburgh Compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: an exploratory study.
Published in:
2010
By:
- Degerman Gunnarsson D;
- Lindau M;
- Wall A;
- Blennow K;
- Darreh-Shori T;
- Basu S;
- Nordberg A;
- Larsson A;
- Lannfelt L;
- Basun H;
- Kilander L
Publication type:
Journal Article
Pittsburgh Compound-B and Alzheimer’s Disease Biomarkers in CSF, Plasma and Urine: An Exploratory Study.
Published in:
Dementia & Geriatric Cognitive Disorders, 2010, v. 29, n. 3, p. 204, doi. 10.1159/000281832
By:
- Gunnarsson, M. Degerman;
- Lindau, M.;
- Wall, A.;
- Blennow, K.;
- Darreh-Shori, T.;
- Basu, S.;
- Nordberg, A.;
- Larsson, A.;
- Lannfelt, L.;
- Basun, H.;
- Kilander, L.
Publication type:
Article
Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Published in:
2009
By:
- Gerhardsson L;
- Blennow K;
- Lundh T;
- Londos E;
- Minthon L
Publication type:
Journal Article
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
Published in:
2009
By:
- Blom ES;
- Giedraitis V;
- Zetterberg H;
- Fukumoto H;
- Blennow K;
- Hyman BT;
- Irizarry MC;
- Wahlund LO;
- Lannfelt L;
- Ingelsson M
Publication type:
Journal Article
Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease.
Published in:
2008
By:
- Buchhave P;
- Stomrud E;
- Warkentin S;
- Blennow K;
- Minthon L;
- Hansson O
Publication type:
Journal Article
Increase in beta-amyloid Levels in cerebrospinal fluid of children with down syndrome.
Published in:
2007
By:
- Englund H;
- Annerén G;
- Gustafsson J;
- Wester U;
- Wiltfang J;
- Lannfelt L;
- Blennow K;
- Hoglund K
Publication type:
Journal Article
Cerebrospinal fluid biomarkers predict decline in subjective cognitive functioning over 3 years in healthy elderly.
Published in:
2007
By:
- Stomrud E;
- Hansson O;
- Blennow K;
- Minthon L;
- Londos E
Publication type:
Journal Article

Found: 150